Ratings NEXTEDIA

Equities

ALNXT

FR0004171346

Market Closed - Euronext Paris 16:14:58 06/05/2024 BST 5-day change 1st Jan Change
0.608 EUR -1.30% Intraday chart for NEXTEDIA -5.00% +4.83%

Strengths

  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
  • The stock, which is currently worth 2024 to 0.34 times its sales, is clearly overvalued in comparison with peers.
  • The company has a low valuation given the cash flows generated by its activity.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company sustains low margins.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last few months, analysts have been revising downwards their earnings forecast.

Ratings chart - Surperformance

Sector: IT Services & Consulting

1st Jan change Capi. Investor Rating ESG Refinitiv
+4.83% 25.88M -
-12.78% 191B
A-
+3.37% 167B
B+
+3.09% 152B
B-
+4.19% 99B
A-
+7.97% 78.79B
A-
+24.48% 75.03B
C-
-7.58% 70.51B
A
-17.75% 53.21B
C
-7.32% 43.78B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes